GLP-1 therapies are changing the treatment of diabetes and obesity, but their growing use also raises questions about nutritional deficiencies, muscle loss, bone health and long-term adherence. Dr Shashank R. Joshi, Consultant, Department of Endocrinology, Sir H. N. Reliance Foundation Hospital, argues that Indian patients need a more comprehensive approach to treatment, combining nutritional assessment, body composition monitoring, strength training and medical supervision rather than focusing on weight reduction alone.
News
GLP-1 Therapies in India Need Tailored Treatment Protocols as Weight Loss Alone Cannot Define Success: Dr Shashank Joshi
November 16, 2026GLP-1 therapies are changing the treatment of diabetes and obesity, but their growing use also raises questions about nutritional deficiencies, muscle loss, bone health and long-term adherence. Dr Shashank R. Joshi, Consultant, Department of Endocrinology, Sir H. N. Reliance Foundation Hospital, argues that Indian patients need a more comprehensive approach to treatment, combining nutritional assessment, body composition monitoring, strength training and medical supervision rather than focusing on weight reduction alone.